Literature DB >> 27769999

Cardiomyopathy-related mutation (A30V) in mouse cardiac troponin T divergently alters the magnitude of stretch activation in α- and β-myosin heavy chain fibers.

Alexis V Mickelson1, Sampath K Gollapudi1, Murali Chandra2.   

Abstract

The present study investigated the functional consequences of the human hypertrophic cardiomyopathy (HCM) mutation A28V in cardiac troponin T (TnT). The A28V mutation is located within the NH2 terminus of TnT, a region known to be important for full activation of cardiac thin filaments. The functional consequences of the A28V mutation in TnT remain unknown. Given how α- and β-myosin heavy chain (MHC) isoforms differently alter the functional effect of the NH2 terminus of TnT, we hypothesized that the A28V-induced effects would be differently modulated by α- and β-MHC isoforms. Recombinant wild-type mouse TnT (TnTWT) and the mouse equivalent of the human A28V mutation (TnTA30V) were reconstituted into detergent-skinned cardiac muscle fibers extracted from normal (α-MHC) and transgenic (β-MHC) mice. Dynamic and steady-state contractile parameters were measured in reconstituted muscle fibers. Step-like length perturbation experiments demonstrated that TnTA30V decreased the magnitude of the muscle length-mediated recruitment of new force-bearing cross bridges (ER) by 30% in α-MHC fibers. In sharp contrast, TnTA30V increased ER by 55% in β-MHC fibers. Inferences drawn from other dynamic contractile parameters suggest that directional changes in ER in TnTA30V + α-MHC and TnTA30V + β-MHC fibers result from a divergent impact on cross bridge-regulatory unit (troponin-tropomyosin complex) cooperativity. TnTA30V-mediated effects on Ca2+-activated maximal tension and instantaneous muscle fiber stiffness (ED) were also divergently affected by α- and β-MHC. Our study demonstrates that TnTA30V + α-MHC and TnTA30V + β-MHC fibers show contrasting contractile phenotypes; however, only the observations from β-MHC fibers are consistent with the clinical data for A28V in humans. NEW & NOTEWORTHY: The differential impact of α- and β-myosin heavy chain (MHC) on contractile dynamics causes a mutant cardiac troponin T (TnTA30V) to differently modulate cardiac contractile function. TnTA30V attenuated Ca2+-activated maximal tension and length-mediated cross-bridge recruitment against α-MHC but augmented these parameters against β-MHC, suggesting divergent contractile phenotypes.
Copyright © 2017 the American Physiological Society.

Entities:  

Keywords:  cross-bridge recruitment; dilated cardiomyopathy; hypertrophic cardiomyopathy; myosin heavy chain; troponin T

Mesh:

Substances:

Year:  2016        PMID: 27769999      PMCID: PMC5283911          DOI: 10.1152/ajpheart.00487.2016

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  46 in total

1.  Different myofilament nearest-neighbor interactions have distinctive effects on contractile behavior.

Authors:  M V Razumova; A E Bukatina; K B Campbell
Journal:  Biophys J       Date:  2000-06       Impact factor: 4.033

2.  Increase in tension-dependent ATP consumption induced by cardiac troponin T mutation.

Authors:  Murali Chandra; Matthew L Tschirgi; Jil C Tardiff
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-07-01       Impact factor: 4.733

3.  The functional effect of dilated cardiomyopathy mutation (R144W) in mouse cardiac troponin T is differently affected by α- and β-myosin heavy chain isoforms.

Authors:  Sampath K Gollapudi; Jil C Tardiff; Murali Chandra
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-02-13       Impact factor: 4.733

4.  Effect of Ca2+ on cross-bridge turnover kinetics in skinned single rabbit psoas fibers: implications for regulation of muscle contraction.

Authors:  B Brenner
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

5.  Spectrum and clinical manifestations of mutations in genes responsible for hypertrophic cardiomyopathy.

Authors:  Karol Curila; Lucie Benesova; Martin Penicka; Marek Minarik; David Zemanek; Josef Veselka; Petr Widimsky; Pavel Gregor
Journal:  Acta Cardiol       Date:  2012-02       Impact factor: 1.718

6.  Cardiac myosin heavy chain isoform exchange alters the phenotype of cTnT-related cardiomyopathies in mouse hearts.

Authors:  Ron Rice; Pia Guinto; Candice Dowell-Martino; Huamei He; Kirsten Hoyer; Maike Krenz; Jeffrey Robbins; Joanne S Ingwall; Jil C Tardiff
Journal:  J Mol Cell Cardiol       Date:  2009-12-31       Impact factor: 5.000

7.  Low prevalence and variable clinical presentation of troponin I and troponin T gene mutations in hypertrophic cardiomyopathy.

Authors:  Karol Curila; Lucie Benesova; Martin Penicka; Marek Minarik; David Zemanek; Josef Veselka; Petr Widimsky; Pavel Gregor
Journal:  Genet Test Mol Biomarkers       Date:  2009-10

8.  Protein kinase A does not alter economy of force maintenance in skinned rat cardiac trabeculae.

Authors:  P P de Tombe; G J Stienen
Journal:  Circ Res       Date:  1995-05       Impact factor: 17.367

9.  Effects of pseudo-phosphorylated rat cardiac troponin T are differently modulated by α- and β-myosin heavy chain isoforms.

Authors:  John Jeshurun Michael; Sampath K Gollapudi; Murali Chandra
Journal:  Basic Res Cardiol       Date:  2014-10-10       Impact factor: 17.165

10.  Divergent effects of α- and β-myosin heavy chain isoforms on the N terminus of rat cardiac troponin T.

Authors:  Ranganath Mamidi; Murali Chandra
Journal:  J Gen Physiol       Date:  2013-09-16       Impact factor: 4.086

View more
  2 in total

1.  Statistical considerations in reporting cardiovascular research.

Authors:  Merry L Lindsey; Gillian A Gray; Susan K Wood; Douglas Curran-Everett
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-07-20       Impact factor: 4.733

2.  Guidelines for authors and reviewers on antibody use in physiology studies.

Authors:  Heddwen L Brooks; Merry L Lindsey
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-01-05       Impact factor: 4.733

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.